ABIOMED, Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended December 31, 2016. For the quarter, the company reported revenue of $114,674,000 against $85,795,000 a year ago. Income from operations was $25,403,000 against $17,443,000 a year ago. Income before income taxes was $25,826,000 against $17,498,000 a year ago. Net income was $15,432,000 against $10,555,000 a year ago. Diluted net income per share was $0.34 against $0.23 per share a year ago.

For the nine months, the company reported revenue of $320,624,000 against $235,586,000 a year ago. Income from operations was $61,144,000 against $45,291,000 a year ago. Income before income taxes was $61,987,000 against $45,611,000 a year ago. Net income was $37,217,000 against $27,149,000 a year ago. Diluted net income per share was $0.83 against $0.61 per share a year ago.

For the year 2017, the company expects revenue guidance with the new range of $440 million to $445 million, an increase in revenue of 34% to 35% from the prior year. This compares to the prior increased forecast of $435 million to $445 million. The Company projects revenue to be around $122 million for the fourth quarter of fiscal 2017 and is maintaining its fiscal year guidance for GAAP operating margin in the range of 18% to 20%.